GlaxoSmithKline to Pay $20 Million to Settle SEC Bribery Probe

GlaxoSmithKline PLC agreed to pay $20 million to settle charges that the drugmaker ’s Chinese subsidiaries engaged in bribery schemes to increase sales in the Asian country, the Securities and Exchange Commission said Friday.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news
More News: Health | Pharmaceuticals